Literature DB >> 19895821

Rational design and biophysical characterization of thioredoxin-based aptamers: insights into peptide grafting.

Christopher J Brown1, Shubhra Ghosh Dastidar, Hai Yun See, David W Coomber, Miguel Ortiz-Lombardía, Chandra Verma, David P Lane.   

Abstract

Peptide aptamers are simple structures, often made up of a single-variable peptide loop constrained within a constant scaffold protein. Aptamers were rationally designed by inserting peptides into a solvent-exposed loop on thioredoxin (Trx). They were designed to interact with the proteins elongation initiation factor 4E (eIF4E) and mouse double minute 2 (MDM2) and were then validated by competitive fluorescence anisotropy experiments. The constructed aptamers interacted with eIF4E and MDM2 with apparent K(d) values of 1.25+/-0.06 microM and 0.09+/-0.01 microM, respectively, as determined by isothermal titration calorimetry (ITC). The MDM2 aptamer (SuperTIP) interacted approximately 2-fold more tightly with MDM2 than the free linear peptide (12.1 peptide), while the eIF4E aptamer elongation initiation factor 4GI-SG interacted approximately 5-fold less strongly than the free linear peptide (elongation initiation factor 4GI). These differences in binding with respect to each aptamer's free peptide reveal that there are more factors involved than just constraining a peptide in a scaffold that lead to tighter binding. ITC studies of aptamer interactions reveal an enthalpic component more favorable than that for the free linear peptides, as well as a larger unfavorable entropic component. These results indicated that stapling of the free peptide in the scaffold increases the favorable enthalpy of the interaction with the target protein. Thermostability studies also revealed that peptide insertion significantly destabilized the Trx scaffold by approximately 27 degrees C. It is this destabilization that leads to an increase in the flexibility of the Trx scaffold, which presumably is lost upon the aptamer's interaction with the target protein and is the cause of the increase in unfavorable entropy in the ITC studies. The precise origin of the enthalpic effect was further studied using molecular dynamics for the MDM2-SuperTIP system, which revealed that there were also favorable electrostatic interactions between the Trx scaffold and the MDM2 protein itself, as well as with the inserted peptide. This work reveals that any increase in the binding affinity of an aptamer over a free peptide is dependent on the increase in the favorable enthalpy of binding, which is ideally caused by stapling of the peptide or by additional interactions between the aptamer protein and its target. These need to be sufficient to compensate for the destabilization of the scaffold by peptide insertion. These observations will be useful in future aptamer designs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19895821     DOI: 10.1016/j.jmb.2009.10.069

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

Review 1.  Developing anti-neoplastic biotherapeutics against eIF4F.

Authors:  Jutta Steinberger; Jennifer Chu; Rayelle Itoua Maïga; Katia Sleiman; Jerry Pelletier
Journal:  Cell Mol Life Sci       Date:  2016-12-21       Impact factor: 9.261

2.  An arsenic fluorescent compound as a novel probe to study arsenic-binding proteins.

Authors:  A Lis Femia; C Facundo Temprana; Javier Santos; María Laura Carbajal; María Silvia Amor; Mariano Grasselli; Silvia Del V Alonso
Journal:  Protein J       Date:  2012-12       Impact factor: 2.371

3.  Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.

Authors:  A Sett; B B Borthakur; U Bora
Journal:  Clin Transl Oncol       Date:  2017-02-21       Impact factor: 3.405

4.  Functional display of bioactive peptides on the vGFP scaffold.

Authors:  Sharon Min Qi Chee; Jantana Wongsantichon; Lau Sze Yi; Barindra Sana; Yuri Frosi; Robert C Robinson; Farid J Ghadessy
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

5.  The MDM2-p53 pathway revisited.

Authors:  Subhasree Nag; Jiangjiang Qin; Kalkunte S Srivenugopal; Minghai Wang; Ruiwen Zhang
Journal:  J Biomed Res       Date:  2013-06-06

6.  Design of nucleotide-mimetic and non-nucleotide inhibitors of the translation initiation factor eIF4E: Synthesis, structural and functional characterisation.

Authors:  Fadi Soukarieh; Matthew W Nowicki; Amandine Bastide; Tuija Pöyry; Carolyn Jones; Kate Dudek; Geetanjali Patwardhan; François Meullenet; Neil J Oldham; Malcolm D Walkinshaw; Anne E Willis; Peter M Fischer
Journal:  Eur J Med Chem       Date:  2016-08-24       Impact factor: 6.514

7.  Combinatorial library of improved peptide aptamers, CLIPs to inhibit RAGE signal transduction in mammalian cells.

Authors:  Sergey Reverdatto; Vivek Rai; Jing Xue; David S Burz; Ann Marie Schmidt; Alexander Shekhtman
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

8.  The novel amyloid-beta peptide aptamer inhibits intracellular amyloid-beta peptide toxicity.

Authors:  Xu Wang; Yi Yang; Mingyue Jia; Chi Ma; Mingyu Wang; Lihe Che; Yu Yang; Jiang Wu
Journal:  Neural Regen Res       Date:  2013-01-05       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.